Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...
Reexamination Certificate
2006-12-26
2006-12-26
Bernhardt, Emily (Department: 1624)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Heterocyclic carbon compounds containing a hetero ring...
C514S255030, C514S252110, C544S360000, C544S392000, C544S393000, C544S394000, C544S357000, C544S364000, C544S382000, C544S295000
Reexamination Certificate
active
07153858
ABSTRACT:
The invention relates to 5-HT receptor agonists or antagonists. Novel arylpiperazinyl sulfonamide compounds represented by Formulae I: and II, and synthesis and uses of those compounds for treating diseases including those mediated directly or indirectly by 5-HT receptors, are disclosed. Such conditions include central nervous system disorders such as generalized anxiety disorder, ADD/ADHD, neural injury, stroke, and migraine. Methods of preparation and novel intermediates and pharmaceutical salts thereof are also included.
REFERENCES:
patent: 5137901 (1992-08-01), Junge et al.
patent: 5300523 (1994-04-01), Junge et al.
patent: 5478828 (1995-12-01), Mattson et al.
patent: 5506246 (1996-04-01), Junge et al.
patent: 5585392 (1996-12-01), Junge et al.
patent: 5602124 (1997-02-01), Tehim et al.
patent: 5789412 (1998-08-01), Halazy et al.
patent: 6391882 (2002-05-01), Moltzen et al.
patent: 6423717 (2002-07-01), Bromidge et al.
patent: 6476050 (2002-11-01), Aquila et al.
patent: 6599904 (2003-07-01), Bromidge et al.
patent: 6635661 (2003-10-01), Cuny et al.
patent: 6645980 (2003-11-01), Cuny et al.
patent: 2001/0056090 (2001-12-01), Aquila et al.
patent: 2002/0016337 (2002-02-01), Cuny et al.
patent: 2002/0035113 (2002-03-01), Moltzen et al.
patent: 2002/0065265 (2002-05-01), Wu et al.
patent: 2002/0123499 (2002-09-01), Persons et al.
patent: 2002/0177721 (2002-11-01), Aquila et al.
patent: 2003/0050309 (2003-03-01), Aquila et al.
patent: 2003/0069233 (2003-04-01), Bromidge et al.
patent: 2003/0069418 (2003-04-01), Aquila et al.
patent: 2003/0073681 (2003-04-01), Hauske et al.
patent: 2003/0092694 (2003-05-01), Nilsson et al.
patent: 2003/0114436 (2003-06-01), Aquila et al.
patent: 2005/0171347 (2005-08-01), Emelen et al.
patent: 089089 (1983-09-01), None
patent: 661266 (1995-07-01), None
patent: 0 946 539 (1999-10-01), None
patent: WO 00/56712 (2000-09-01), None
patent: WO 03/009850 (2003-02-01), None
Uchida et al. Chemical Abstracts vol. 127, No. 220471 (1997) (Abstract for JP 09202764, Aug. 5, 1997).
Bojarski, et al.,Bioorganic Med. Chem., 10:3817-3827 (2002).
Oh, et al.,Curr. Med. Chem., 8:999-1034 (2001).
Rasmussen, et al.,J. Pharmacol. Experimental Therapeutics, 294(2):688-700 (2000).
Lopez-Rodriguez et al. J. Med. Chem. vol. 44, pp. 198-207 (2001).
Becker et al. J. Med. Chem. vol. 49, pp. 3116-3135 (2006).
Bar-Haim Shay
Becker Oren
Chen Dongli
Cheruku Srinivasa Rao
Dhanoa Dale S.
Bernhardt Emily
Epix Delaware, Inc.
Goodwin & Procter LLP
Triano, III Nicholas P.
LandOfFree
Arylpiperazinyl compounds does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Arylpiperazinyl compounds, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Arylpiperazinyl compounds will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3671949